Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P von Hoegen

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Immunology and Cell Biology|August 1, 1995
Deficiency in T cell responses of human fetal lymph node cells: a lack of accessory cellsP von Hoegen, S Sarin, J F Krowka
Cancer Research|September 1, 1985
Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigensP Altevogt, P von Hoegen, S Leidig, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Adhesion versus coreceptor function of CD4 and CD8: role of the cytoplasmic tail in coreceptor activityM C Miceli, P von Hoegen, J R Parnes
Nature|May 21, 1992
An immunological role for the CD8 beta-chainC J Wheeler, P von Hoegen, J R Parnes
Gene Therapy|September 25, 1998
Superiority of the ear pinna over muscle tissue as site for DNA vaccinationP Förg, P von Hoegen, W Dalemans, et al.
Immunology and Cell Biology|August 1, 1993
Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigensV Schirrmacher, H J Schild, B Gückel, et al.
European Journal of Immunology|December 1, 1987
CD4+ helper T cells are required for resistance to a highly metastatic murine tumorH J Schild, B Kyewski, P Von Hoegen, et al.
European Journal of Immunology|February 1, 1989
Antibody 12-15 cross-reacts with mouse Fc gamma receptors and CD2: study of thymus expression, genetic polymorphism and biosynthesis of the CD2 proteinP Altevogt, U Kohl, P Von Hoegen, et al.
Invasion & Metastasis|January 1, 1989
Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additional signalsP von Hoegen, R Heicappell, A Griesbach, et al.
The Journal of Infectious Diseases|February 10, 1999
Immunization with human immunodeficiency virus type 1 rgp120W61D in QS21/MPL adjuvant primes T cell proliferation and C-C chemokine production to multiple epitopes within variable and conserved domains of gp120W61DG J Jones, P von Hoegen, J Weber, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Immunology and Cell Biology|August 1, 1995
Deficiency in T cell responses of human fetal lymph node cells: a lack of accessory cellsP von Hoegen, S Sarin, J F Krowka
Cancer Research|September 1, 1985
Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigensP Altevogt, P von Hoegen, S Leidig, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Adhesion versus coreceptor function of CD4 and CD8: role of the cytoplasmic tail in coreceptor activityM C Miceli, P von Hoegen, J R Parnes
Nature|May 21, 1992
An immunological role for the CD8 beta-chainC J Wheeler, P von Hoegen, J R Parnes
Gene Therapy|September 25, 1998
Superiority of the ear pinna over muscle tissue as site for DNA vaccinationP Förg, P von Hoegen, W Dalemans, et al.
Immunology and Cell Biology|August 1, 1993
Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigensV Schirrmacher, H J Schild, B Gückel, et al.
European Journal of Immunology|December 1, 1987
CD4+ helper T cells are required for resistance to a highly metastatic murine tumorH J Schild, B Kyewski, P Von Hoegen, et al.
European Journal of Immunology|February 1, 1989
Antibody 12-15 cross-reacts with mouse Fc gamma receptors and CD2: study of thymus expression, genetic polymorphism and biosynthesis of the CD2 proteinP Altevogt, U Kohl, P Von Hoegen, et al.
Invasion & Metastasis|January 1, 1989
Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additional signalsP von Hoegen, R Heicappell, A Griesbach, et al.
The Journal of Infectious Diseases|February 10, 1999
Immunization with human immunodeficiency virus type 1 rgp120W61D in QS21/MPL adjuvant primes T cell proliferation and C-C chemokine production to multiple epitopes within variable and conserved domains of gp120W61DG J Jones, P von Hoegen, J Weber, et al.
Pageof 4